Understanding the impact of hemophilia severity on symptoms
Hemophilia is a genetic disorder that affects the blood’s ability to clot, leading to prolonged bleeding. This condition varies widely in severity, which significantly impacts both the symptoms experienced and the daily life of individuals. Hemophilia A, in particular, is classified into 3 categories: mild, moderate, and severe. Understanding these severity levels and their effects is crucial for patients living with hemophilia A and their caregivers.
Hemophilia severity levels and the effect
on symptoms
The severity of hemophilia A is determined by the baseline level of clotting Factor VIII present in the blood. Those with mild hemophilia A have Factor VIII levels ranging from 5% to less than 40%. Individuals with moderate hemophilia have Factor VIII levels between 1% and 5%, while severe hemophilia A is defined by Factor VIII levels of less than 1%.
The severity of hemophilia significantly impacts the symptoms experienced by individuals. Common signs and symptoms of severe hemophilia include prolonged and/or unexplained bleeding, easy bruising, joint pain, and swelling. These symptoms can interfere with daily activities and overall quality of life. For instance, individuals with severe hemophilia may experience frequent and spontaneous bleeding episodes, while those with mild hemophilia might only face significant bleeding after surgery or injury.
Mild hemophilia symptoms
Individuals with mild hemophilia often experience severe bleeding after surgery, injury, or dental work. However, spontaneous bleeding episodes are rare. Most individuals with mild hemophilia are treated with on-demand medications. Prophylaxis therapy, which involves regular treatment to prevent bleeding, also plays an important role in reducing the frequency and severity of bleeding episodes. This therapy helps maintain joint health.
Patients with mild hemophilia symptoms may go undiagnosed until a significant bleeding episode occurs, often leading to a later diagnosis in life. Early detection and management are essential to prevent complications and ensure a better quality of life. Working closely with a healthcare provider is important to develop a personalized treatment plan that addresses individual needs.
Moderate hemophilia symptoms
Those with moderate hemophilia symptoms can experience bleeding episodes after minor trauma or surgeries. They may also suffer from extensive hematomas (large blood clots under the skin) and prolonged bleeding. Joint bleeding, even with minor trauma, can result in pain and joint stiffness. Although spontaneous bleeding into joints and muscles is less frequent than in severe cases, it can still occur and cause significant discomfort and mobility issues.
Effective management of moderate hemophilia involves regular monitoring and possibly prophylactic treatment to prevent bleeding episodes and maintain joint health. This approach can help individuals lead more active lives. Collaborating with a healthcare provider is crucial to create a personalized care plan that fits each patient's unique situation.
Severe hemophilia symptoms
Individuals with severe hemophilia often experience frequent and spontaneous bleeding episodes, sometimes without an apparent cause. Common bleeding sites include joints, muscles, and soft tissues. These individuals may require prophylactic treatment to prevent spontaneous bleeding and manage symptoms. Without adequate treatment, severe hemophilia can lead to joint deformities, chronic pain, and life-threatening bleeding in areas like the brain.
Prophylactic treatment for severe hemophilia has significantly improved the quality of life for many patients, helping to prevent severe complications and allowing them to engage in more physical activities safely. Understanding the signs and symptoms of severe hemophilia is crucial for timely intervention and management. Patients should work closely with their healthcare providers to develop a personalized treatment plan that effectively manages their condition.
Understanding the impact of hemophilia severity on symptoms is crucial for effective management and improving the quality of life for individuals with hemophilia A. Patients and caregivers should discuss their symptoms and treatment options with their healthcare providers to develop a personalized care plan. With advances in treatment and comprehensive care, individuals with hemophilia A can lead healthier and more fulfilling lives.
Find your CoRe Manager and connect today!
Sanofi Hemophilia Community Relations and Education (CoRe) Managers offer education to
people living with hemophilia and their families. CoRe Managers provide information about
living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe
team member nearest you.
ALTUVIIIO® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Your healthcare provider may give you ALTUVIIIO when you have surgery.
What is the most important information I need to know about ALTUVIIIO?
Do not attempt to give yourself an injection unless you have been taught how by your healthcare provider or hemophilia center. You must carefully follow your healthcare provider’s instructions regarding the dose and schedule for injecting ALTUVIIIO so that your treatment will work best for you.
Who should not use ALTUVIIIO?
You should not use ALTUVIIIO if you have had an allergic reaction to it in the past.
What should I tell my healthcare provider before using ALTUVIIIO?
Tell your healthcare provider if you have had any medical problems, take any medications, including prescription and non-prescription medicines, supplements, or herbal medicines, are breastfeeding, or are pregnant or planning to become pregnant.
What are the possible side effects of ALTUVIIIO?
You can have an allergic reaction to ALTUVIIIO. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called “inhibitors” against ALTUVIIIO. This can stop ALTUVIIIO from working properly. Your healthcare provider may give you blood tests to check for inhibitors.
The common side effects of ALTUVIIIO are headache and joint pain.
These are not the only possible side effects of ALTUVIIIO. Tell your healthcare provider about any side effect that bothers you or does not go away.
Please see full Prescribing Information.
Learn more about Sanofi’s commitment to fighting counterfeit drugs.
![ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/.imaging/default/dam/Marketing/AltuviiioUS/altuviiio.webp/jcr:content.webp)